high throughput screening core
-
February 11, 2013
VU, GlaxoSmithKline team to develop novel treatments for severe obesity
Vanderbilt University has signed a collaboration agreement with GlaxoSmithKline (GSK) for the discovery, development and commercialization of novel therapies for severe obesity.